检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:高玉龙[1] 王春梅[1] 朱小玲[1] 艾辉[1] 李艳芳[1]
机构地区:[1]首都医科大学附属北京安贞医院抢救中心,北京100029
出 处:《临床心血管病杂志》2013年第5期344-347,共4页Journal of Clinical Cardiology
摘 要:目的:观察糖化血红蛋白(HbA1c)水平对急性心肌梗死(AMI)患者接受直接冠状动脉介入(PCI)术后心肌组织灌注的影响。方法:选择因AMI行直接PCI的患者492例,根据HbA1c水平将所有患者分为HbA1c≥6.5%组189例和HbA1c<6.5%组(对照组)303例。通过观察TIMI心肌灌注(TMP)分级、心肌blush分级(MBG)及术后ST段回落率(STR),评价2组患者的术后心肌组织灌注及预后。结果:与对照组比较,HbA1c≥6.5%组的病变血管数、术中出现无复流/慢血流比例、住院期间病死率及梗死相关动脉开通时间显著增加,而术后达到TIMI血流3级、MBG 3级、TMP 3级和STR的比例及LVEF均明显降低(均P<0.05)。多因素分析结果显示,HbA1c≥6.5%是影响术后STR(OR=2.156,95%CI:1.057~4.328,P=0.036)及住院期间病死率(OR=1.021,95%CI:0.418~2.412,P=0.022)的独立危险因素。结论:HbA1c升高的AMI患者心肌组织灌注较差,住院期间病死率高。应重视这些高危患者,并尽早处理,从而改善患者的预后。Objective:To investigate the effect of glycosylated hemoglobin (HbAlc) on myocardial tissue per-fusion in patients with acute myocardial infarction (AMI) during primary percutaneous coronary intervention (PCI). Method: A total of 492 patients with AMI undergoing primary PCI were enrolled and divided into HbAlc≥ 6.5% group and HbAlc〈6.5% group (control group). The TIMI myocardial perfusion (TMP) grade, myocar-dial blush grade (MBG) and ST-segment resolution (STR) were recorded. Result:Compared with control group, the number of diseased vessels, the no reflow/slow flow ratio, the in-hospital mortality and the opening time of infraction-related arteries were significantly higher, while the rate of TIMI flow 3 grade, MBG 3 grade, TMP 3 grade, STR post intervention and LVEF were lower in the HbAlc≥6.5% group(all P〈0.05). Logistic analysis showed that HbAlc≥6.5%0 was an independent risk factor for STR (OB=2. 156, 95%CI: 1. 057-4. 328, P= 0. 036) and in-hospital mortality (OR= 1. 021, 95%CI: 0. 418-2. 412,P=0. 022). Conclusion:The high level of HhAlc is a predictor of poor myocardial tissue perfusion after PCI in patients with AMI. Patients with high HbAlc should be paid more attention and treated early to improve the prognosis.
关 键 词:急性心肌梗死 糖化血红蛋白 直接冠状动脉介入治疗 心肌组织灌注 预后
分 类 号:R542.2[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.54